<VariationArchive VariationID="190159" VariationName="NM_000124.4(ERCC6):c.2096dup (p.Leu700fs)" VariationType="Duplication" Accession="VCV000190159" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2015-05-09" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="188000" VariationID="190159">
      <GeneList>
        <Gene Symbol="ERCC6" FullName="ERCC excision repair 6, chromatin remodeling factor" GeneID="2074" HGNC_ID="HGNC:3438" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="49434881" stop="49539538" display_start="49434881" display_stop="49539538" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="50664490" stop="50747146" display_start="50664490" display_stop="50747146" Strand="-" />
          </Location>
          <OMIM>609413</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000124.4(ERCC6):c.2096dup (p.Leu700fs)</Name>
      <CanonicalSPDI>NC_000010.11:49482759:G:GG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>10q11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="49482759" stop="49482760" display_start="49482759" display_stop="49482760" variantLength="1" positionVCF="49482759" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="50690805" stop="50690806" display_start="50690805" display_stop="50690806" variantLength="1" positionVCF="50690805" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>L700fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_465" sequenceAccession="LRG_465">
            <Expression>LRG_465:g.61342dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_465t1" sequenceAccession="LRG_465t1">
            <Expression>LRG_465t1:c.2096dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000124.3" sequenceAccession="NM_000124" sequenceVersion="3" change="c.2096dup">
            <Expression>NM_000124.3:c.2096dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.50690806dup" Assembly="GRCh37">
            <Expression>NC_000010.10:g.50690806dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.49482760dup" Assembly="GRCh38">
            <Expression>NC_000010.11:g.49482760dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009442.1" sequenceAccession="NG_009442" sequenceVersion="1" change="g.61342dup">
            <Expression>NG_009442.1:g.61342dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000124.4" sequenceAccession="NM_000124" sequenceVersion="4" change="c.2096dup" MANESelect="true">
            <Expression>NM_000124.4:c.2096dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000115.1" sequenceAccession="NP_000115" sequenceVersion="1" change="p.Leu700fs">
            <Expression>NP_000115.1:p.Leu700fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001346440.2" sequenceAccession="NM_001346440" sequenceVersion="2" change="c.2096dup">
            <Expression>NM_001346440.2:c.2096dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001333369.1" sequenceAccession="NP_001333369" sequenceVersion="1" change="p.Leu700fs">
            <Expression>NP_001333369.1:p.Leu700fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA274700" DB="ClinGen" />
        <XRef Type="rs" ID="774791374" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000124.4(ERCC6):c.2096dup (p.Leu700fs) AND Cockayne syndrome type 2" Accession="RCV000170377" Version="1">
        <ClassifiedConditionList TraitSetID="433">
          <ClassifiedCondition DB="MedGen" ID="C0751038">Cockayne syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2012-09-07" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000124.4(ERCC6):c.2096dup (p.Leu700fs) AND multiple conditions" Accession="RCV000668158" Version="1">
        <ClassifiedConditionList TraitSetID="43959">
          <ClassifiedCondition DB="MedGen" ID="C0220722">Cerebrooculofacioskeletal syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0751038">Cockayne syndrome type 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0265201">DE SANCTIS-CACCHIONE SYNDROME</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-07-20" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000124.4(ERCC6):c.2096dup (p.Leu700fs) AND not provided" Accession="RCV001046396" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-30" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-05-09" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18628313</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28170084</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29572252</ID>
        </Citation>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="43959" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="930" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">DE SANCTIS-CACCHIONE SYNDROME</ElementValue>
                <XRef ID="De+Sanctis-Cacchione+Syndrome/2123" DB="Genetic Alliance" />
                <XRef Type="MIM" ID="278800" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609413.0002" DB="OMIM" />
                <XRef ID="414673004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Xerodermic idiocy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ERCC6</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8276" />
                <XRef ID="8276" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1569" DB="Orphanet" />
              <XRef ID="C0265201" DB="MedGen" />
              <XRef ID="MONDO:0010217" DB="MONDO" />
              <XRef Type="MIM" ID="278800" DB="OMIM" />
            </Trait>
            <Trait ID="1524" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cockayne Syndrome, Type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome  type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cockayne syndrome type 2</ElementValue>
                <XRef ID="MONDO:0019570" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome B</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CSB</ElementValue>
                <XRef Type="MIM" ID="133540" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1420" />
                <XRef ID="1420" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes: CS type I, the "classic" or "moderate" form; CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome; CS type III, a milder and later-onset form; COFS syndrome, a fetal form of CS. CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years. CS type III is a phenotype in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I. COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).</Attribute>
                <XRef ID="NBK1342" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301516</ID>
                <ID Source="BookShelf">NBK1342</ID>
              </Citation>
              <XRef ID="191" DB="Orphanet" />
              <XRef ID="90322" DB="Orphanet" />
              <XRef ID="C0751038" DB="MedGen" />
              <XRef ID="MONDO:0019570" DB="MONDO" />
              <XRef Type="MIM" ID="133540" DB="OMIM" />
            </Trait>
            <Trait ID="1348" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cerebro-oculo-facio-skeletal syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cerebrooculofacioskeletal syndrome 1</ElementValue>
                <XRef ID="MONDO:0008955" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">COFS1</ElementValue>
                <XRef Type="MIM" ID="214150" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15150" />
                <XRef ID="15150" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C0220722" DB="MedGen" />
              <XRef ID="MONDO:0008955" DB="MONDO" />
              <XRef Type="MIM" ID="214150" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="433" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1524" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cockayne Syndrome, Type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome  type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cockayne syndrome type 2</ElementValue>
                <XRef ID="MONDO:0019570" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome B</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CSB</ElementValue>
                <XRef Type="MIM" ID="133540" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1420" />
                <XRef ID="1420" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes: CS type I, the "classic" or "moderate" form; CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome; CS type III, a milder and later-onset form; COFS syndrome, a fetal form of CS. CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years. CS type III is a phenotype in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I. COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).</Attribute>
                <XRef ID="NBK1342" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301516</ID>
                <ID Source="BookShelf">NBK1342</ID>
              </Citation>
              <XRef ID="191" DB="Orphanet" />
              <XRef ID="90322" DB="Orphanet" />
              <XRef ID="C0751038" DB="MedGen" />
              <XRef ID="MONDO:0019570" DB="MONDO" />
              <XRef Type="MIM" ID="133540" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="405028" SubmissionDate="2015-04-13" DateLastUpdated="2015-05-09" DateCreated="2015-05-09">
        <ClinVarSubmissionID localKey="NM_000124.3:c.2096dupC|OMIM:133540" />
        <ClinVarAccession Accession="SCV000222792" DateUpdated="2015-05-09" DateCreated="2015-05-09" Type="SCV" Version="1" SubmitterName="Claritas Genomics" OrgID="1179" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-09-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2007</Attribute>
          <Citation>
            <ID Source="PubMed">18414213</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000124.3:c.2096dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cockayne syndrome, type B</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="133540" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1543016" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="458802|OMIM:133540;214150;278800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000792712" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="CG" referenceAllele="C" start="50690805" stop="50690805" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000124.2:c.2096dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="133540" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="214150" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="278800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2375604" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4884867|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001210296" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28170084</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18628313</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29572252</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 190159). This premature translational stop signal has been observed in individual(s) with clinical features of Cockayne syndrome (PMID: 28170084). This variant is present in population databases (rs774791374, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Leu700Valfs*60) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.50690805_50690806insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1543016" TraitType="Disease" MappingType="XRef" MappingValue="133540" MappingRef="OMIM">
        <MedGen CUI="C0751038" Name="Cockayne syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1543016" TraitType="Disease" MappingType="XRef" MappingValue="214150" MappingRef="OMIM">
        <MedGen CUI="C0220722" Name="Cerebrooculofacioskeletal syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1543016" TraitType="Disease" MappingType="XRef" MappingValue="278800" MappingRef="OMIM">
        <MedGen CUI="C0265201" Name="DE SANCTIS-CACCHIONE SYNDROME" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="405028" TraitType="Disease" MappingType="Name" MappingValue="Cockayne syndrome, type B" MappingRef="Preferred">
        <MedGen CUI="C0751038" Name="Cockayne syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2375604" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

